Researchers found that intranasal lidocaine is effective in the treatment of acute migraine and cluster headache because of its ability to block the sphenopalatine ganglion, which is associated with facial pain from the trigeminal nerve.
Short-term use of calcitonin-gene-related peptide (CGRP) binding monoclonal antibodies was well-tolerated and safe when used to prevent episodic migraine, according to a study published in Cephalalgia. The investigators of this study sought to evaluate and compare the safety and tolerability of CGRP binding monoclonal antibodies for the preventative treatment of episodic migraine. The investigators systematically…
Investigators found that using a fat injection technique to treat patients with migraine headache using small divisions over an array into nerves identified as migraine triggers, such as the trigeminal and cervical nerve branches, was successful in the majority of patients treated.
Researchers found an association between migraines and reduced cerebral endothelial dysfunction, and patients at a younger age are at a higher risk for stroke and cerebrovascular reactivity, which is effected by longer disease duration.
The 7-item Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome Role Function-Restrictive domain was found to represent a reliable and valid tool for assessing the functional impact in participants of clinical trials of episodic and chronic migraine.
The demographic characteristics and migraine diagnosis of pediatric patients with headache were found to be associated with the use of evidence-based medicine and prescriptions for opioids and barbiturates as first-line treatment.
